Objective: Depressive symptoms after stroke have been associated with negative outcomes, including poorer functional ability, less efficient use of rehabilitation services, decreased quality of life, and increased mortality. It has been anecdotally noted that depressive symptoms do not limit motor recovery in patients who undergo Constraint-Induced Movement Therapy (CIMT), an efficacious intervention for chronic poststroke hemiparesis. Here we analyze depressive symptom and motor scores from 40 participants who received CIMT in 2 previously published studies. Method: Adults more than 1-year after stroke with mild to moderate upperextremity hemiparesis completed the Zung Self-Rating Depression Scale and Motor Activity Log (MAL) before and after CIMT. We used regression analysis to test whether Zung scores predicted response to CIMT and paired t tests to test whether depressive symptoms changed from pre-to posttreatment. Results: Pretreatment Zung score did not predict outcome on the MAL Arm Use scale, ⌬R 2 (1, 30) ϭ 0.004, p ϭ .19, after controlling for pretreatment MAL scores. Additionally, participants had a small but statistically significant decrease in Zung score, t(39) ϭ 3.0, p ϭ .005, mean change ϭ Ϫ3.6. Conclusion: These results suggest that depressive symptoms do not significantly limit motor recovery in patients treated with CIMT for chronic poststroke hemiparesis. Additionally, treatment with CIMT may improve depressive symptoms.
Introduction
Depressive disorders are one of the most common and welldocumented comorbidities after stroke, with a prevalence of 20%-30%, depending on the instrument used (Astrom, Adolfsson, & Asplund, 1993; Hackett, Kohler O'Brien, & Mead, 2014; Robinson & Jorge, 2016) . Depressive disorders are often diagnosed in inpatients shortly after first stroke onset, and may be long lasting (Ferro, Caeiro, & Figueira, 2016) . Depressive disorders are generally a negative prognostic indicator after stroke, and have been associated with increased mortality, less efficient use of rehabilitation services, and greater functional impairment than outcomes for those who experienced similar stroke symptoms but were not depressed (Hadidi, Treat-Jacobson, & Lindquist, 2009; Matsuzaki, Hashimoto, Yuki, Koyama, Hirata, & Ikeda, 2015; Paolucci, Antonucci, Pratesi, Traballesi, Grasso, & Lubich, 1999) . Depressive disorders limit motivation and are associated with increased fatigue and feelings of hopelessnesss (G. Gillen, 2006; R. Gillen, Eberhardt, Tennen, Affleck, & Groszmann, 1999; Schubert, Taylor, Lee, Mentari, & Tamaklo, 1992) . These factors may interfere with patients' participation in rehabilitation, creating a vicious cycle whereby depressed individuals become increasingly physically disabled, which in turn worsens depressive symptoms (Herr-mann, Black, Lawrence, Szekely, & Szalai, 1998; O'Dell, Lin, & Harrison, 2009) . Depressive disorders predict poor rehabilitation outcomes over and above poststroke cognitive impairment (R. Gillen, Tennen, McKee, Gernert-Dott, & Affleck, 2001) and are linked to an inactive and dependent lifestyle following discharge from rehabilitation (Clark & Smith, 1998 . In particular, depressive disorders are associated with reduced ability for activities of daily living (ADLs) and social activities (Chen, Leys, & Esquenazi, 2013; Hadidi et al., 2009 ). As might be expected, depressive disorders are additionally associated with a significantly decreased quality of life (Guajardo et al., 2015; Smith, 2015) . Overall, there is a clear consensus in the literature that depressive disorders can adversely affect poststroke rehabilitation programs, as well as treatment for a large number of other conditions (DeJean, Giacomini, Vanstone, & Brundisini, 2013; Fernie, Kollmann, & Brown, 2015; Ford, 2008; Harpole et al., 2005; Katon, 2003; Katon, Lin, & Kroenke, 2007; Robinson & Jorge, 2016) .
Although the poor prognosis of depressive disorders is a pressing concern when implementing or studying poststroke rehabilitation interventions, the literature suggests that depressive disorders are generally addressed separately from physical therapy rather than through a comprehensive rehabilitation program. Screening for depressive disorders is now common, and antidepressant medications are the typical treatment of choice (Flaster, Sharma, & Rao, 2013; Robinson & Jorge, 2016) . While not common practice, parallel to findings in adults without brain injury (Karyotaki et al., 2016) , a combination of brief psychosocial therapy and antidepressant medication has been found to be superior to antidepressant medication alone in treating depressive disorders in adults after stroke (Mitchell et al., 2009; Williams et al., 2007) . Notably, it is unclear whether pharmacologic treatments successfully mitigate all of the negative impacts of depressive disorders on rehabilitation outcome (Esparrago Llorca, Castilla-Guerra, Fernandez Moreno, Ruiz Doblado, & Jimenez Hernandez, 2015; Flaster et al., 2013) . In one recent study, depressive disorders had a poor prognosis for ADLs regardless of both participation in a rehabilitation program and treatment with antidepressants (Paolucci et al., 1999) .
Constraint-Induced Movement Therapy (CIMT) is efficacious for motor deficit following stroke or other central nervous system injury (Taub et al., 1993) . Originally developed through basic neuroscience research in nonhuman primates (Taub, 1976 (Taub, , 1980 , CIMT improves motor function in part by overcoming a behaviorally conditioned inhibition or suppression of use of the moreaffected arm, a phenomenon termed learned nonuse (Taub, 1976; Taub, Uswatte, Mark, & Morris, 2006 ). An important factor for overcoming learned nonuse is implementing a group of behavioral techniques called the "Transfer Package," which focuses on facilitating transfer of gains made in the treatment setting to improved performance of ADLs in the real-world setting (Taub et al., 2013) . Therefore, the improvement produced by CIMT is particularly large for spontaneous use of the more-affected arm in real-world activities as measured by the Motor Activity Log (see below); the mean effect size across studies is d= ϭ 3.0 (Taub et al., 1993; Taub, Uswatte, King, et al., 2006; Taub et al., 2013) . A large value of d= is considered to be at least 0.57 (Cohen, 1988) . CIMT also improves motor function by increasing motor capacity; the therapy produces a substantial improvement in the quality and speed of movement of the more-affected upper extremity as measured by the Wolf Motor Function Test (mean effect size across studies is d= ϭ 0.93; Taub et al., 1993 Taub et al., , 2013 Taub, Uswatte, King, et al., 2006) .
It has been anecdotally noted that patients undergoing CIMT do not seem to have their motor recovery adversely affected by depressive disorders, but the interaction of depressive disorders with CIMT treatment outcome had not been systematically evaluated. The present study compiled data from two patient groups who underwent CIMT in this laboratory to determine whether depressive symptoms significantly affected physical treatment outcome, and whether depressive symptoms had changed during the treatment.
Method Participants
This was a retrospective study of 40 adults who had been treated with CIMT for chronic poststroke upper-extremity hemiparesis during previous studies from this laboratory (Taub, Uswatte, King, et al., 2006; Taub et al., 2013) . The general inclusion criteria were (a) stroke Ն1 year prior and (b) mild-to-moderate upper-extremity hemiparesis (Taub et al., 2013) . The general exclusion criteria were (a) substantial use of the more-affected arm in daily life as indicated by a score Ͼ2.5 on the Motor Activity Log (see below); (b) major cognitive deficits (Ͻ24 points on the Folstein MiniMental State Examination) or aphasia severe enough to prevent valid performance on sample test items during screening; (c) pain, spasticity, ataxia, or frailty severe enough to interfere with participation in treatment in the judgment of the clinician conducting screening; and (d) severe end-stage or uncontrolled medical conditions. Mean age was 58.3 Ϯ 11.8 years and mean chronicity was 3.1 Ϯ 3.6 years. The sample was 55% female. Detailed participant characteristics are presented in Table 1 . Thirteen (32%) of the 40 participants scored at or above the cut-off for a depressive disorder on the screening instrument that we used (see below).
Measures
Zung Self-Rating Depression Scale. The Zung (Zung, 1965; Zung, Richards, & Short, 1965 ) is a 20-item, self-report measure that has been widely used in research to assess the severity of depressive symptoms. Respondents are asked to rate the frequency of depressive symptoms. Response scale anchors are 1 (a little of the time); 2 (some of the time); 3 (good part of the time); and 4 (most of the time). To calculate the test score (range ϭ 25-100), relevant items are reverse scored, item scores are summed, and the sum is multiplied by 1.25. Test scores Ն57 are considered to mark depressive symptoms that are severe enough to warrant attention from a clinician. The Zung was chosen for use with CIMT patients because it had been validated in stroke. Internal consistency was more than adequate (Cronbach's alpha ϭ .83) in 40 adults with stroke (Agrell & Dehlin, 1989) . In the same study, convergent validity was supported by a correlation of .72 with a global rating of depressive symptom severity derived from a psychiatric interview, while concurrent validity was supported by correlations of 0.75 and 0.73 with the Geriatric Depression Scale and Center for Epidemiologic Studies Depression Scale This document is copyrighted by the American Psychological Association or one of its allied publishers.
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(CES-D), respectively. The positive predictive value for the cutoff noted above for clinically significant depressive symptoms was 93%. In another study of 27 adults with stroke, the correlation between the Zung and CES-D was .65 (Shinar et al., 1986) . Motor Activity Log. The MAL (Taub et al., 1993 ) is the primary outcome measure for CIMT. It is a structured interview that asks patients to rate the amount and quality of their current real-world use of their more-affected arm relative to that before stroke. Responses are provided on a 0-to 5-point Likert scale. The abbreviated version of the response anchors are 0 (no use of the more-affected arm); 1 (very poor use); 2 (poor use); 3 (fair use); 4 (almost normal use); and 5 (use equivalent to that before stroke). The MAL is reliable and valid (Uswatte et al., 2005; Uswatte, Taub, Morris, Light, & Thompson, 2006; van der Lee, Beckerman, Knol, de Vet, & Bouter, 2004) . Because the two MAL scales are highly correlated, only the scale for quality of use is reported, and is hereafter referred to as the Arm Use Scale .
Treatment
Upper-extremity CIMT for patients involved (a) intensive training of the more-affected arm on movements and activities of functional significance with rest periods as needed for 3 hr/day for 10 consecutive weekdays for one study (Taub et al., 2013) and 6 hr/day for the other (Taub, Uswatte, King, et al., 2006) ; (b) training by behavioral shaping, which involves approaching motor goals in small increments, with strong encouragement to improve on personal best performance and positive feedback at each step; (c) restraint of the less-affected hand with a padded mitt for a target 90% of waking hours; and (d) a set of behavioral procedures, termed the Transfer Package, to facilitate transfer of training benefits from the clinic to the real world (Taub et al., 2013) . Transfer Package procedures include (a) behavioral contracting, (b) home practice assignments to be conducted during and after the end of formal treatment, (c) keeping an activity diary, and (d) the therapist conducting 30-min daily interviews with the patient that include administering the MAL, reviewing the diary, and problemsolving discussions to overcome perceived barriers to arm use. For a detailed description of the CIMT protocol, see Taub et al. (2013) .
Procedures
Participants completed the MAL and Zung before and after CIMT. A subset of participants (n ϭ 16) had an additional MAL completed independently by a caregiver to corroborate the patient's report of real-world use of the more-affected arm.
All participants provided informed consent, and all study procedures were approved by the institutional review board at the University of Alabama at Birmingham.
Data Analysis
Paired-samples t tests evaluated change in MAL Arm Use and Zung scores from pre-to posttreatment. Simple, bivariate correlations were calculated among selected demographic variables and pre-and posttreatment MAL and Zung scores. Hierarchical linear regression was conducted to determine whether pretreatment Zung score significantly predicted posttreatment MAL score after controlling for pretreatment MAL score. Assumptions for linear regression were met.
Results

Pre-to Posttreatment Change in Real-World Arm Use
The participants displayed large improvements on the MAL Arm Use scale from pre-to posttreatment, t(39) ϭ 16.5, p Ͻ .001, d= ϭ 3.3; the mean change was 2 points (SD ϭ 0.6; see Table 2 ).
Severity of Poststroke Depressive Symptoms and CIMT Outcome
Pretreatment Zung score did not predict posttreatment MAL Arm Use score after controlling for pretreatment MAL score, ⌬R Arm Use 2 (1, 37) ϭ 0.004, p ϭ .19. Likewise, pretreatment Zung Note. The data in this study are from participants in two previously published constraint induced movement therapy studies (see Footnotes a and b, below). There were no statistically significant differences in the variables tabled between the participants from the two original studies. a Taub et al. (2013) . b Taub, Uswatte, King, et al. (2006) . This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
score did not predict outcome on caregiver-reported MAL scores for the subsample of participants that had these data available, ⌬R Caregive Arm Use 2 (1, 13) ϭ 0.04, p ϭ .42. Demographic variables (age, sex, race, time since stroke) were not significantly correlated with either Zung or MAL scores, and thus were not included in the regression model (see Table 3 ). The mean change on the MAL Arm Use scale for participants with Zung scores above and below the cutoff for clinically significant depressive symptoms at pretreatment was similar: 2.1 (SD ϭ 0.66, n ϭ 13) versus 1.8 (SD ϭ 0.74, n ϭ 27), respectively, for participants with Zung scores above and below the cutoff, t(12) ϭ Ϫ0.98, p ϭ .35.
Change in Poststroke Depressive Symptoms
The patients had a small but statistically significant decrease in Zung score from pre-to posttreatment, t(39) ϭ 3.0, p ϭ .005, mean change ϭ Ϫ3.6, SD change ϭ 7.5. Mean Zung scores at pretreatment and posttreatment were 51.3 Ϯ 9.8 and 47.6 Ϯ 10.4, respectively. Of the 13 participants who scored in the range marking clinically significant depressive symptoms on the Zung before treatment, seven (54%) no longer endorsed symptoms in that range after CIMT.
Discussion
Most importantly, severity of depressive symptoms did not predict motor improvement after CIMT. This is notable because depressive symptoms after stroke have frequently been demonstrated to impede rehabilitation outcome as well as use of rehabilitation services (R. Gillen et al., 1999; Robinson et al., 2016; Sinyor et al., 1986; van de Weg, Kuik, & Lankhorst, 1999) . Despite this common finding, depressive symptom severity does not appear to be associated with worse motor recovery of patients treated in this laboratory with CIMT. The 13 patients scoring in the range marking clinically significant symptoms on the Zung still had a strong positive response to CIMT, achieving at least the laboratory average improvement during the course of their treatment. Furthermore, treatment with CIMT had an impact on depressive symptoms. A statistically significant reduction in Zung scores was observed in the entire sample. The magnitude of the change, however, was too small to be clinically meaningful. Inspection of pre-to posttreatment changes in the subgroup of patients who scored above the Zung cutoff for clinically significant symptoms before CIMT, however, revealed a different picture. Over half of the patients who scored above the Zung cutoff before CIMT, that is, 7 out of 13, fell below the cutoff afterward. This is an observational study regarding the relationship between depressive symptoms and CIMT in adults after stroke; it is not designed to permit causal attributions. Nevertheless, it is possible to speculate regarding why CIMT outcome was not impeded by depressive symptom severity. The first factor may be related to the efficacy of CIMT (Taub, Uswatte, King, et al., 2006; Taub et al., 2013) . The treatment period was just two weeks. Within this span, the participants, who were all in the chronic phase (mean chronicity ϭ 3.1 years), observed a marked improvement in the use of their more-affected arm after years in which no change or a deterioration occurred. Moreover, CIMT specifically Note. The data in this study are from participants in two previously published Constraint-Induced Movement therapy studies (see Footnotes a and b, below). There were no statistically significant differences in pre-treatment scores or change scores between participants from the original studies. Asterisks represent the significance levels of paired t tests evaluating the pre-to posttreatment changes within each sample. a Taub et al. (2013) . b Taub, Uswatte, King, et al. (2006) . Note. Chronicity ϭ years since stroke; Pre ϭ pretreatment; Post ϭ posttreatment; MAL ϭ Motor Activity Log Arm Use Scale; Zung ϭ Zung Depression Scale. ‫ء‬ p Ͻ .01. This document is copyrighted by the American Psychological Association or one of its allied publishers.
focuses on the transfer of gains made in the treatment setting to spontaneous use of the more-affected extremity for ADLs in the real-world setting. Through the Transfer Package techniques, including the aforementioned home practice exercises and problem solving with the therapist, patients work toward performing a larger number of manual tasks than before treatment and performing the tasks with the more-affected arm, with as little assistance from the less-affected arm and others in their home as possible. Previous literature on depressive disorders after stroke has suggested that loss of independence and decreased social participation are associated with the negative impacts of depressive symptoms, and may create a vicious circle by which a patient becomes concurrently more dependent and depressed (O'Dell et al., 2009; Smith, 2015) . The focus on facilitating improvement of ADLs and regaining independence during CIMT may combat these harmful effects. This is also in line with previous research that has suggested rehabilitation therapies focusing on improving ADLs and life participation may be particularly beneficial for patients with depressive symptoms after stroke (Smith, 2015) . Second, the participants in these studies were in the chronic phase of recovery. Such individuals are frequently socially isolated, which could promote depressive tendencies. On entering CIMT, they are surrounded by cheerful personnel who, in accordance with the protocol, strongly and warmly encourage and reinforce improving performance. Moreover, our participants almost invariably show clinically meaningful improvement on the MAL (Ն1 MAL point; Lang et al., 2008) in the short span of the usual 2-week treatment period, with improvement on a day-to-day basis that is usually discernable to participants. According to the treatment protocol, personnel are tasked to frequently and prominently point out that the improvements are due to the participants' own efforts, thereby enhancing their sense of self-efficacy. These factors appear to be a powerful means of neutralizing the usual effects of depressive symptoms on treatment outcome. Indeed, CIMT even has the converse effect of producing a small but significant elevation in mood.
Third, CIMT focuses on activities that are personally important to patients. In-laboratory motor tasks are chosen based on the specific nature of patients' deficits as well as their goals. Likewise, patients and their caregivers are given a wide variety of choices regarding their home practice assignments and other activities completed outside the laboratory or clinic. There is an additional problem-solving component during which the therapist works with the patient and family members, if available, to address real or perceived barriers to completing the activities selected for attention. Working toward specific goals that are chosen and valued by the patient may provide additional motivation to consistently comply with and participate in the intervention, and may combat feelings of helplessness or hopelessness associated with depressive disorders.
As noted, over half of the participants who scored in the range on the Zung marking clinically significant depressive symptoms before CIMT scored outside that range afterward. In addition to the factors discussed above as possible explanations for the robustness of CIMT treatment change to the presence of depressive symptoms, another possible factor contributing to the improvement in depressive symptoms is that voxel-based morphometric analysis of structural MRI scans from stroke patients before and after CIMT has revealed increased gray matter in the hippocampus afterward (Gauthier et al., 2008) . If this increase reflects neurogenesis, this neuroplastic response might contribute to reducing depressive symptoms. Animal studies suggest neurogenesis in the hippocampus plays a causal role in alleviating depressive symptoms (Santarelli et al., 2003) .
It is also worth noting that CIMT is a physically intensive treatment, and therefore may have a positive impact on depressive symptoms, at least partially through the effects of exercise. It is well documented that increasing patients' physical activity has a positive impact on depressive symptoms in both healthy individuals and those with a chronic illness (Herring, Puetz, O'Connor, & Dishman, 2012; Pedersen & Saltin, 2015) . A further connection has been demonstrated between sedentary lifestyle, which may characterize many patients with depressive symptoms and motor deficits after stroke, and persistent or worsening depression (Hallgren et al., 2016) . In these patients, simply increasing engagement in ADLs with some degree of physical activity may benefit depressive symptoms. CIMT, with its rigorous treatment-setting physical component and active home practice assignments, may improve depressive symptoms through both of these mechanisms.
Important limitations of this study were the retrospective design and modest sample size. A potential source of bias was that the Zung and MAL are both self-report measures, raising the possibility that any association observed between the two instruments might be inflated by having a common method of measurement. In this case, however, Zung scores were not correlated with MAL scores at pretreatment, r(39) ϭ Ϫ.24, p ϭ .14, or posttreatment, r(39) ϭ Ϫ.01, p ϭ .97, reducing the salience of this concern.
Future studies would be valuable to determine the duration and extent of retention of improved Zung Scale scores after CIMT and to more specifically examine the detailed interactions of elements of the CIMT treatment protocol and depressive symptom severity. It would also be worthwhile to examine whether there are specific types of depressive symptoms (e.g., low motivation, feelings of hopelessness) that are influenced by treatment with CIMT, or perhaps affect the quality of CIMT clinical outcomes. It would also be valuable to evaluate the relation of executive function in patients with depressive disorders after stroke to CIMT outcome, and to quantify factors such as self-efficacy, motivation, selfregulation, and attention. Such work might provide insight into techniques that could be used improve motor treatment outcome for patients with depressive disorders after stroke in general, as well as potential strategies for improving depressive symptoms themselves during the rehabilitation program.
Conclusion
While the current study is preliminary, the general results appear to be clear. Patients who were treated with CIMT achieved laboratory average improvement regardless of depressive symptoms. Thus, depressive symptom severity does not predict the outcome of CIMT, whereas this is the case for many other standard rehabilitation interventions and treatments for other conditions. CIMT might provide explicit support in areas in which rehabilitation patients with depressive symptoms are vulnerable, a type of support which in many other approaches to rehabilitation is less systematic. The explicit forms of support in CIMT include frequent positive feedback on performance, a warm therapeutic environment, and elements that promote transfer of therapeutic gains This document is copyrighted by the American Psychological Association or one of its allied publishers.
to the real world. Another factor may be the rapid and easily perceived improvement in motor function produced by the treatment. Treatment with CIMT may facilitate a small improvement in depressive symptoms, and may do so through a positive approach to treatment and a focus on increased motivation, participation, and independence. The results of the current study suggest that CIMT would be a particularly advantageous approach to improving motor function in patients with depressive disorders after stroke.
